Refreshing results…
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma
UploadPatient‐derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib
UploadResistance to Targeted Agents Used to Treat Paediatric ALK-Positive ALCL
Download from doi.orgThe Role of Autophagy and lncRNAs in the Maintenance of Cancer Stem Cells
Download from doi.orgSTAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma
Download from www.nature.comExistence of reprogrammed lymphoma stem cells in a murine ALCL-like model
Download from www.nature.comNPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
Download from doi.orgThe Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
Download from doi.orgChallenging perspectives on the cellular origins of lymphoma
Download from royalsocietypublishing.orgMissing publications? Search for publications with a matching author name.